Page 17 - Amryt Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

European biotech enjoys a burst of dealmaking activity | White & Case LLP

European biotech just enjoyed its most abundant quarter in nearly two years in a tentative sign of a renaissance in the sector. There were 46 deals in Q1 2023, the second biggest year.

Amryt pharmaChiesi farmaceuticiWhite caseNational institutes of healthRhythm pharmaceuticalsWestern europe bidderGlobal sectorsTotal market biotechnology indexNasdaq biotechnology indexEpidermolysis bullosaNational institutes

Lomitapide Shows Promise in Pediatric Homozygous FH

Children and adolescents with homozygous familial hypercholesterolemia could benefit from lomitapide therapy, suggests a trial, although safety concerns and upcoming novel drugs question its place.

Baden wübergComunidad autonoma de catalunaAmryt pharmaLuis masanaAndreas zirlikUniversity of grazDrug administrationDepartment of cardiologyEuropean atherosclerosis societyEuropean medicines agencyUniversity heart center grazVascular medicineMetabolism unitSant joan de reu university hospitalUniversity hospitalMedical university

Amryt Pharma (LON:AMYT) Shares Pass Below 50-Day Moving Average of $143 00

Amryt Pharma plc (LON:AMYT – Get Rating)’s stock price passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of GBX 143 ($1.79) and traded as low as GBX 143 ($1.79). Amryt Pharma shares last traded at GBX 143 ($1.79), with a volume of 90,727 shares changing […]

Amryt pharmaGet ratingPharma trading downAmryt pharma dailyLon amyt

Cognition Therapeutics, Inc (CGTX) Appoints John Doyle as CFO

Cognition Therapeutics, Inc (CGTX) Appoints John Doyle as CFO
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Amryt pharmaLisa ricciardiJohn doyleNational institutes of healthHologic incParexel incCognition therapeutics incSimplivity corpUniversity of massachusettsChiasma incWall streetVerastem oncologyNational institutes

AlphaCentric Advisors LLC Acquires 25,000 Shares of Amryt Pharma plc (NASDAQ:AMYT)

AlphaCentric Advisors LLC increased its position in shares of Amryt Pharma plc (NASDAQ:AMYT – Get Rating) by 44.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 81,000 shares of the company’s stock after acquiring an additional 25,000 shares during the period. AlphaCentric Advisors […]

Amryt pharmaCanaccord genuity groupRenaissance technologiesSilverarc capital managementRoyal bankMaxim groupAlphacentric advisorsCantor fitzgeraldExchange commissionGet ratingCentric advisorsCapital managementState street corpGenuity groupVisit holdingschannelAmryt pharma daily